See more : PT GTS Internasional Tbk (GTSI.JK) Income Statement Analysis – Financial Results
Complete financial analysis of Tilray Brands, Inc. (TLRY) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Tilray Brands, Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Many Bright Ideas Technologies Inc. (MBGNF) Income Statement Analysis – Financial Results
- RF Acquisition Corp II Ordinary Shares (RFAI) Income Statement Analysis – Financial Results
- The Nanto Bank, Ltd. (8367.T) Income Statement Analysis – Financial Results
- BF Investment Limited (BFINVEST.BO) Income Statement Analysis – Financial Results
- Daewoo Engineering & Construction Co., Ltd. (047040.KS) Income Statement Analysis – Financial Results
Tilray Brands, Inc. (TLRY)
About Tilray Brands, Inc.
Tilray Brands, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. It offers medical and adult-use cannabis products, including GMP-certified flowers, oils, vapes, edibles, and topicals; purchases and resells pharmaceutical and wellness products; and produces, markets, sells, and distributes beverage alcohol products, and hemp-based food and other wellness products. The company offers its products under the Tilray, Aphria, Broken Coast, Symbios, B!NGO, The Batch, P'tite Pof, Dubon, Good Supply, Solei, Chowie Wowie, Canaca, RIFF, SweetWater, Breckenridge Distillery, Alpine Beer Company, and Green Flash brands. It sells its products to retailers, wholesalers, patients, physicians, hospitals, pharmacies, researchers, and governments, as well as direct to consumers. The company was formerly known as Tilray, Inc. Tilray Brands, Inc. is headquartered in Leamington, Canada.
Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 788.94M | 627.12M | 628.37M | 513.09M | 391.00M | 175.25M | 28.63M | 15.17M | 6.47M | 443.70K | 0.00 | 0.00 |
Cost of Revenue | 565.59M | 480.16M | 511.56M | 389.90M | 253.31M | 119.50M | 3.97M | 2.33M | 1.88M | 567.59K | 0.00 | 0.00 |
Gross Profit | 223.35M | 146.96M | 116.82M | 123.18M | 137.68M | 55.74M | 24.66M | 12.84M | 4.58M | -123.89K | 0.00 | 0.00 |
Gross Profit Ratio | 28.31% | 23.43% | 18.59% | 24.01% | 35.21% | 31.81% | 86.13% | 84.63% | 70.87% | -27.92% | 0.00% | 0.00% |
Research & Development | 635.00K | 682.00K | 1.52M | 830.00K | 1.85M | 1.03M | 380.00K | 365.52K | 168.99K | 55.95K | 0.00 | 0.00 |
General & Administrative | 171.56M | 165.16M | 162.80M | 111.58M | 88.30M | 70.83M | 24.64M | 5.25M | 2.21M | 5.33M | 45.34K | 98.51K |
Selling & Marketing | 79.17M | 65.78M | 65.86M | 44.12M | 29.92M | 20.67M | 9.21M | 4.95M | 2.76M | 579.52K | 0.00 | 0.00 |
SG&A | 250.72M | 230.94M | 228.66M | 155.69M | 118.22M | 91.50M | 33.85M | 10.20M | 4.97M | 5.91M | 45.34K | 98.51K |
Other Expenses | 146.74M | -66.91M | 115.19M | 35.22M | 15.68M | 10.41M | 1.98M | 379.96K | 277.37K | -3.28M | 0.00 | 0.00 |
Operating Expenses | 398.10M | 325.11M | 345.37M | 191.74M | 135.75M | 102.94M | 37.32M | 11.28M | 5.42M | 6.01M | 45.34K | 98.51K |
Cost & Expenses | 963.69M | 805.27M | 856.93M | 581.64M | 389.07M | 222.44M | 34.24M | 13.61M | 7.30M | 5.81M | 45.34K | 98.51K |
Interest Income | 12.83M | 33.03M | 11.74M | 2.93M | 5.79M | 10.61M | 4.93M | 827.91K | 215.83K | 104.79K | 3.35K | 2.08K |
Interest Expense | 49.26M | 13.59M | 39.68M | 30.90M | 24.78M | 5.75M | 1.05M | 287.34K | 215.83K | 104.79K | 3.35K | 2.08K |
Depreciation & Amortization | 126.91M | 130.15M | 115.19M | 35.22M | 15.68M | 16.95M | 5.18M | 1.44M | 730.05K | 306.47K | 0.00 | 0.00 |
EBITDA | -72.84M | -889.52M | -246.40M | -218.36M | -18.40M | -36.66M | -658.00K | 4.37M | 115.11K | -5.06M | -1.43M | -608.47K |
EBITDA Ratio | -9.23% | -18.32% | 42.73% | 5.90% | 17.18% | 8.19% | -2.55% | 28.80% | -1.73% | -1,141.18% | 0.00% | 0.00% |
Operating Income | -174.75M | -1.37B | 153.30M | -4.95M | 51.48M | -2.60M | -9.64M | -1.03M | -836.23K | -2.73M | -45.34K | -98.51K |
Operating Income Ratio | -22.15% | -218.41% | 24.40% | -0.96% | 13.17% | -1.48% | -33.66% | -6.81% | -12.93% | -615.78% | 0.00% | 0.00% |
Total Other Income/Expenses | -74.28M | -80.50M | 169.73M | -212.82M | -5.18M | 100.79M | 40.23M | 151.61K | 221.29K | -2.53M | 0.00 | 2.08K |
Income Before Tax | -249.02M | -1.45B | -440.67M | -344.99M | -58.19M | -11.56M | 27.81M | 3.22M | -614.94K | -5.27M | -41.99K | -96.43K |
Income Before Tax Ratio | -31.56% | -231.24% | -70.13% | -67.24% | -14.88% | -6.60% | 97.13% | 21.20% | -9.51% | -1,186.63% | 0.00% | 0.00% |
Income Tax Expense | -26.62M | -7.18M | -6.54M | -8.97M | 2.82M | 631.19K | 4.97M | 99.29K | -920.06K | -3.38M | 0.00 | 0.00 |
Net Income | -244.98M | -1.44B | -434.13M | -336.01M | -61.02M | -12.19M | 22.84M | 3.12M | 305.12K | -5.27M | -41.99K | -96.43K |
Net Income Ratio | -31.05% | -230.10% | -69.09% | -65.49% | -15.61% | -6.96% | 79.77% | 20.54% | 4.72% | -1,186.63% | 0.00% | 0.00% |
EPS | -0.33 | -2.34 | -0.90 | -1.25 | -0.61 | -0.06 | 0.17 | 0.04 | 0.01 | -0.14 | -0.01 | -0.04 |
EPS Diluted | -0.33 | -2.34 | -0.90 | -1.25 | -0.61 | -0.06 | 0.16 | 0.04 | 0.01 | -0.14 | -0.01 | -0.04 |
Weighted Avg Shares Out | 742.65M | 617.98M | 481.22M | 269.55M | 100.46M | 203.46M | 134.96M | 87.45M | 48.98M | 38.04M | 3.34M | 2.31M |
Weighted Avg Shares Out (Dil) | 742.65M | 617.98M | 481.22M | 269.55M | 100.46M | 203.46M | 139.05M | 93.39M | 48.98M | 38.04M | 3.34M | 2.31M |
Tilray Brands narrows net loss but misses sales forecast for Q1
Tilray Brands (TLRY) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
Tilray Brands, Inc. (TLRY) Reports Q1 Loss, Lags Revenue Estimates
Tilray's stock gains after earnings and upbeat outlook on cannabis legalization
Markets Up Ahead of CPI, Jobless Claims Thursday
3 Cannabis Stocks to Monitor as the Election Approaches
Tilray Q1 Preview: Germany Could Drive Earnings Surprise
Insights Into Tilray Brands (TLRY) Q1: Wall Street Projections for Key Metrics
Tilray Brands Launches Charlotte's Web™ CBD Gummies in Canada
Tilray Brands stock forecast: levels to watch ahead of earnings
Source: https://incomestatements.info
Category: Stock Reports